Skip to main content
. 2026 Aug 27;14:1888829. doi: 10.3389/fpubh.2026.1888829

Table 3.

Characteristics of included studies.

References Country Setting Population (and numbers screened) Study design Intervention (and duration) Eligibility criteria/guideline Outcome Recruitment strategy
Age Smoking history Others
Shah et al. (29) USA Emergency Services Firefighters who are members of the Chicago Fire Department Local 2 Union (n = 1,347) Prospective cohort study LDCT (April 2022–June 2023) – – • No minimum service requirements.
• Exclusion criteria: having a chest CT within the past year.
• Continued screening per the 2021 USPSTF LCS guidelines
recommended, if a nodule was detected.
Prevalence of Lung RADS category 3 or 4 (high–risk) nodules Not reported
Grolleau et al. (30) France Healthcare Employees at Lyon University Hospital (LUH) (n = 144) Prospective implementation study LDCT (Sept. 2022–May 2024) 50–75 years Smoking more than 15 cigarette/day for 25 years or more than 10 cigarettes/day for 30 years; being current or former smokers who quit since less than 15 years • French LCS guidelines.
• or having a PLCOm2012 score ≥ 1.51%; or both
Participation rate Combination of info displays (flyers, posters); e–mails; and face–to–face interaction through department heads, occupational medicine, and specially trained nurses
Kim et al. (31) South Korea Hospitality Food service workers (n = 203) Cross–sectional study LDCT (June 2022–Aug. 2022) ≥ 55 years – • Had been working for ≥ 10 years
• No history of tuberculosis, asthma, or other cancer before screening
Lung–RADS distribution Not reported
Cabral et al. (32) Portugal Mining A subgroup of former miners of the Uranium National Company (n = 66) Retrospective cohort study LDCT a (In 2015) – A smoking load greater than 20 pack–years Exposure to uranium Prevalence of pulmonary nodules; Lung–RADS distribution Not reported
Brims et al. (33) Australia Diverse* Participants in the Western Australia Asbestos Review Program (n = 1,743) Prospective Cohort study LDCT (August 2012–August 2017) – – Participants must have had a minimum of 3 months of occupational asbestos exposure and/or radiographically confirmed pleural plaques to participate in the program Incidence rate of lung cancer Primary care
Heidrich et al. (34) Germany Diverse* German former workers with occupational asbestos exposure (OAE) of ≥ 10 years with onset before 1985 (n = 9,277) Program evaluation LDCT a ≥55 years smoking history of ≥30 pack years Occupational asbestos exposure (OAE) of ≥10 years with onset before 1985 Participation rates and detection rate of lung cancer Not reported
Evaluation period: 2014–2021 (Program ongoing)
Chen et al. (35); Liang et al. (50) China Healthcare Employees of Guangdong Provincial People's Hospital Guangzhou China (n = 2,633) Prospective cohort study LDCT (Jan. 2019–March 2024) ≥40 years old – – Detection rate of pulmonary nodules and incidence rate of lung cancer Not reported
Anzai et al. (36) Japan Engineering Employees of Hamamatsu Photonics Engineering Company Japan (n = 1,213) Prospective cohort study Biomarker + Chest X–ray (2009–2019) >40 years – – • Cancer detection rate
• Cancer–related mortality
• Cancer–related Health care cost
Not reported
Chung et al. (37) South Korea Shipbuilding Shipyard workers, who underwent health examinations with LDCT (n = 6,326) Retrospective cohort study LDCT (Jan. 2010 – Dec. 2018) – – • Inclusion Criteria: unclear Lung RADS distribution; prevalence of Lung–RADS category ≥ 3; detection rate of lung cancer Not reported
• Exclusion criteria: female workers (due to their small number); missing information on job type, medical history, and smoking history; never undergone LDCT; and diagnosed with lung cancer before 2010
Zhang et al. (38) China Healthcare Employees (including retired) from 6 hospitals in different regions of China (n = 8,392) Retrospective cohort study LDCT (2012–2018) – – Inclusion Criteria: unclear Detection rate of lung cancer Not reported
Billatos et al. (39) USA Armed Forces Veterans Prospective cohort study Biomarkers + LDCT • DECAMP 1: ≥45 years • DECAMP 1: Current or former cigarette smoker with ≥20 pack–year exposure – Prevalence of lung cancer; Incidence of lung cancer Specialty clinics in pulmonary, thoracic surgery and thoracic oncology
DECAMP 1: (n = 500 planned, 489 actual)
• DECAMP 1: 2013–2022 (completed) • DECAMP 2: 50–79 years
• DECAMP 2: (n = 800 planned, 665 recruited as of 2024)
• DECAMP 2: Current or former cigarette smoker (≥10 cigarettes/day for at least 25 years' duration for current smokers, or ≥ 20 pack years for former smokers who quit 20 years ago or less)
• DECAMP 2: 09.2011–12.2027 (ongoing)
Welch et al. (40) USA Construction Workers who had participated in a BTMed screening from 2011 to 2016 and were invited to participate in the Early Lung Cancer Detection (ELCD) Program (n = 1,290) Prospective cohort Study LDCT b (2011–2016) 55–74 years Current smokers with at least 30 pack–years or those who have quit within the past 15 years • Formerly NCCN (V.2012); Since 2014 NCCN Guideline (Version 1.2014)
• Additional requirement of 5 years of work in the construction industry or 5 years of work in a job with exposures to asbestos, silica, beryllium, chromium, radiation or welding
Detection rate of lung cancer; Physical and psychosocial status Not reported
Markowitz et al. (41) USA Construction Former nuclear weapons workers in 9 non–metropolitan US communities from 2000 −2013 (n = 7,189) Prospective cohort study LDCT b (2000–2013) 50 years or older (no upper age limit) Had smoked for 1 year or longer Occupation; radiographic asbestos–related fibrosis; and a positive beryllium lymphocyte proliferation test Detection rate of lung cancer; and Screening Yield per risk factor Not reported
Barbone et al. (42) Italy Construction Former workers enrolled in the Monfalcone Occupational Health surveillance program for asbestos exposure and resident in the FVG region in early 2002 (n = 926) Prospective cohort study LDCT (Feb. 2002–Oct. 2003) 40–75 years Both smokers and non–smokers were eligible Definite exposure to asbestos, no previous cancer (except non–melanoma skin cancer), no severe comorbidities, no clinical suspicion of lung cancer or MNP and no chest CT scan during the previous 2 years Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) Not reported
Abtahi et al. (43) Iran Glass wool manufacturing Employees of a glass wool company (n = 145) Analytical Cross–sectional study Biomarkers (Serum CEA and CYFRA 21–1 Levels) No age No smoking history limitation Only employees working 8 hours a day Concentration levels of serum CEA and CYFRA 21–1 Not reported
Kato et al. (44) Japan Diverse* Workers with histories of asbestos exposure enrolled between 2010 and 2012 (n = 2,132) Descriptive Cross–sectional study LDCT (2010–2012) – – • Engagement in asbestos–product manufacturing for more than 1 year
• Engagement in other industries related to asbestos exposure for more than 10 years, or
• Engagement in industries related to asbestos exposure and demonstrated pleural plaques on chest X–ray or CT (regardless of the duration of asbestos exposure)
Prevalence of lung cancer and malignant pleural mesothelioma (MPM) Not reported
Smargiassi et al. (45) Italy Diverse* Former male asbestos–exposed workers in the Campania Region of Italy (n = 59) Descriptive Cross–sectional study LDCT + Chest ultrasonography (Nov. 2015 –Feb. 2016) – – Occupational exposure to asbestos fibers before 1992 Detection rate of pathological findings like Pleural thickening, peripheral lung consolidation, pulmonary asbestosis, etc. E–mails only
Gaballah et al. (46) Egypt Wood Male workers in the carpentry section of wooden furniture manufacturer in an Egyptian modernized industrial factory located in Greater Cairo (n = 86) Analytical Cross–sectional study Sputum PCR – – Excluded moderate to heavy smokers (Smoking Index ≥ 20 pack years) Inclusion Criteria:
• Wood dust exposure at the workplace for more than 5 years
Frequency of chromosomal aberrations (CA) and sister chromatid exchanges (SCE) in peripheral blood lymphocytes (PBL); Superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzymes levels Not reported
Exclusion Criteria:
• Exposures with other chemical exposures at workplace in addition to wood dust.
• Present history of hypertension or diabetes.
• Familial history of any type of cancer.
• Abnormal liver function tests.
Okereke et al. (47) USA Armed Forces US Veterans at the Providence VAMC in Providence, Rhode Island (n = 1,832) Retrospective review LDCT a (Dec. 2013–Dec. 2014) 55–74 years Current smokers or quit within the past 15 years; and had at least a 30–pack–year smoking history – Detection rate of lung cancer Primary care
Felten et al. (48) Germany Power Asbestos–exposed employees of a major provider of electrical power in Germany (n = 187) Prospective cohort study LDCT and sputum cytology (Sept. 2002–July 2006) ≤75 years old – Signed declaration of past contact with asbestos Detection rate of lung cancer; Pathological findings Not reported
Mastrangelo et al. (49) Italy Diverse* • Categories of workers with the highest risk of asbestos exposure in the Veneto Region of Italy (n = 1,165) Program evaluation LDCT b 55–59 years – Only males included • Detection rate of lung cancer
• Incidence rate of lung cancer
• Cost
• Radiation dose
Invitation letters to participants and their family physicians
• 2000–2005 (LCS project)
• 2006–2011 (on–demand health surveillance)
• b) All workers, whatever the previous level of asbestos exposure, as part of an on–demand health surveillance (n = 3,149)

aIncluding a shared decision–making.

bIncluding a smoking cessation intervention.

*Diverse refers to when participants of a LCS program are recruited from a combination of different occupational settings or industries, particularly those characterized with Asbestos Exposure.